Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06384950
Status:
RECRUITING
Last Update Posted:
2024-04-25
First Post:
2024-04-16
Brief Title:
Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma
Sponsor:
Taipei Veterans General Hospital Taiwan
Organization:
Taipei Veterans General Hospital Taiwan
Study Overview
Official Title:
Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Liver cancer is a leading cause of cancer-related deaths in Taiwan with its onset linked to factors like chronic liver conditions cirrhosis and genetic predispositions According to the Barcelona Clinic Liver Cancer BCLC classification early-stage liver cancer is demarcated by stages 0 to A Upon such diagnosis both patients and their families often have numerous questions and concerns ranging from treatment choices to long-term outcomes The research proposes a GPT-35-based chatbot to assist these patients by providing timely personalized information aiming to enrich their understanding of the disease and improve communication between patients and health professionals
The research methodology employs a Randomized Controlled Trial RCT design dividing participants into a control cohort receiving standard patient education routine and an experimental cohort receiving both the AI chatbot and traditional education routine The comparative analysis of these cohorts will determine the effectiveness of the AI intervention in improving patients health literacy and satisfaction
The research methodology employs a Randomized Controlled Trial RCT design dividing participants into a control cohort receiving standard patient education routine and an experimental cohort receiving both the AI chatbot and traditional education routine The comparative analysis of these cohorts will determine the effectiveness of the AI intervention in improving patients health literacy and satisfaction
Detailed Description:
Liver cancer is the second most common cause of cancer-related deaths in Taiwan Various factors play a role in its development such as chronic liver conditions cirrhosis viral infections alcohol intake obesity diabetes and genetic predispositions among others Based on the Barcelona Clinic Liver Cancer BCLC system early-stage liver cancer falls within stages 0 to A When faced with an early-stage liver cancer diagnosis patients and their relatives frequently express concerns These may range from the potential effects of the disease on daily living evaluating treatment options potential side effects costs involved the chances of recurrence and survival rates to the care required after the treatment Addressing these worries often requires extensive explanations and time for the patients to process the information
The research proposes using a chatbot built upon the GPT-35 language model developed by OpenAI for patient education services Such a chatbot would aid early-stage liver cancer patients navigate the complexities of obtaining relevant information As an artificial intelligence technology the chatbot can offer timely personalized information and psychological support By responding to patients inquiries the chatbot can provide a thorough understanding of basic liver cancer knowledge its causes and treatment approaches thereby facilitating a deeper comprehension of the early stages of liver cancer and its treatment regimen Patients and their relatives can comprehend their condition and treatment plans enhancing their conversations with medical staff and promoting a harmonious doctor-patient relationship
The research uses a Randomized Controlled Trial RCT methodology dividing patients into a control group undergoing the conventional patient education routine and an experimental group that leverages both the chatbot and traditional education By comparing selected outcomes between the two groups the experiments effectiveness will be determined
The research proposes using a chatbot built upon the GPT-35 language model developed by OpenAI for patient education services Such a chatbot would aid early-stage liver cancer patients navigate the complexities of obtaining relevant information As an artificial intelligence technology the chatbot can offer timely personalized information and psychological support By responding to patients inquiries the chatbot can provide a thorough understanding of basic liver cancer knowledge its causes and treatment approaches thereby facilitating a deeper comprehension of the early stages of liver cancer and its treatment regimen Patients and their relatives can comprehend their condition and treatment plans enhancing their conversations with medical staff and promoting a harmonious doctor-patient relationship
The research uses a Randomized Controlled Trial RCT methodology dividing patients into a control group undergoing the conventional patient education routine and an experimental group that leverages both the chatbot and traditional education By comparing selected outcomes between the two groups the experiments effectiveness will be determined
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None